Abstract: Compounds of the formula (I), in which R1, Q and Het have the meanings indicated in Claim 1), are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumours.
Type:
Application
Filed:
August 6, 2008
Publication date:
December 9, 2010
Applicant:
MERCK PATENT GESELLSCHAFT MIT ESCHRANKTER HAFTUNG
Inventors:
Oliver Schadt, Dieter Dorsch, Frank Stieber, Andree Blaukat